Page 1 of 1

Has this treatment been abandoned?

Posted: Tue Jul 09, 2019 6:04 pm
by daniel
Doesn’t seem to be any updates in this forum. I’m personally still taking my daily 3x100mg biotin dose and I was just wondering if I’m missing some news...

Re: Has this treatment been abandoned?

Posted: Wed Jul 10, 2019 5:41 am
by Zyklon
https://www.mstrust.org.uk/news/news-ab ... -licensing

https://www.ema.europa.eu/en/documents/ ... tin_en.pdf
The European Medicines Agency (EMA) has been examining data on high dose biotin (MD1003, Qizenday) since the application was accepted in September 2016. At a meeting last week, the EMA's Committee for Medicinal Products for Human Use (CHMP) concluded that the clinical data from two trials that enrolled 253 patients was not sufficient (link is external) to assess the effectiveness or the safety of biotin.
Still has the potential with larger and better clinical trials.

Re: Has this treatment been abandoned?

Posted: Wed Jul 10, 2019 11:10 am
by ElliotB
"Doesn’t seem to be any updates in this forum."

There really are no updates at this time and have not been any developments for a couple of years. There never really was and there is still no conclusive evidence that this treatment really works.

Medday is currently in the middle of a Phase 3 trial. The trial is currently active in 90 sites worldwide — 48 in the U.S. and Canada, 39 in Europe, and three in Australia. MedDay expects first results to be available in early 2020. We will just have to wait patiently until they announce the results next year. Here is some info about it:

https://multiplesclerosisnewstoday.com/ ... announces/

I still take it as well and plan to continue taking it regardless of the findings of the trial. I had been taking it in lower doses for a few years prior to their announcement and of course increased the dosage according to their recommendations. Biotin is an important nutrient for numerous reasons and it is a good supplement to take.